SKI Market

A+| A| A-|

Indian Indices

Sensex

79,191.47 671.17
( 0.85%)

Global Indices

Nasdaq

49,464.98 -3.46
(-0.01%)

Dow Jones

7,130.75 -16.31
(-0.23%)

Hang Seng

59,361.39 536.50
(0.91%)

Nikkei 225

10,604.22 -63.41
(-0.59%)

Forex

USD-INR

92.58 -0.61
(-0.65%)

EUR-INR

108.87 -0.98
(-0.89%)

GBP-INR

125.07 -1.17
(-0.93%)

JPY-INR

0.58 0.00
(-0.45%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Nava Ltd

Industry : Diversified - Large

BSE Code

ISIN Demat

Book Value()

513023

INE725A01030

132.2629187

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

NAVA

37.41

19883.67

EPS(TTM)

Face Value()

Div & Yield %

18.78

1.14

Back

Solara Active Pharma Sciences reports consolidated net loss of Rs 10.10 crore in the September 2025 quarter

Nov 05,2025

Net loss of Solara Active Pharma Sciences reported to Rs 10.10 crore in the quarter ended September 2025 as against net profit of Rs 8.01 crore during the previous quarter ended September 2024. Sales declined 9.63% to Rs 313.54 crore in the quarter ended September 2025 as against Rs 346.95 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	313.54	346.95	-10
OPM %	11.08	17.67	-
PBDT	14.39	33.35	-57
PBT	-10.10	8.01	PL
NP	-10.10	8.01	PL

79,191.47 671.17 ( 0.85%)

49,464.98 -3.46 (-0.01%)

7,130.75 -16.31 (-0.23%)

59,361.39 536.50 (0.91%)

10,604.22 -63.41 (-0.59%)

92.58 -0.61 (-0.65%)

108.87 -0.98 (-0.89%)

125.07 -1.17 (-0.93%)

0.58 0.00 (-0.45%)